CLOUDS OF CARE
Clouds of Care provides AI-powered biomarker platform services for central nervous system clinical trials, specializing in EEG-based endpoints for rare and complex neurological conditions.
Clouds of Care accelerates the adoption of objective neurophysiological endpoints through a multimodal AI-powered biomarker platform across CNS indications. The company offers clinical development services to de-risk and streamline CNS clinical trials, and operates as a curated network of solutions connected via one platform. They specialize in EEG-based biomarker services for rare and complex CNS clinical trials, with particular focus on epilepsy and developmental and epileptic encephalopathies.
Key People
Jeroen Crappe - COO